High dose therapy/ASCT consolidated with rituximab and or alpha interferon immunotherapy for relapsed follicular lymphoma prolongs progression free survival and achieves durable molecular remissions.

被引：0
|
作者：
Buckstein, RJ
Mangel, J
Imrie, K
Spaner, D
Crump, M
Pennell, N
Boudreau, A
Reis, M
Robinson, J
Romans, R
Richardson, P
Nagy, T
Berinstein, N
机构：
[1] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto Sunnybrook Reg Canc Ctr, Adv Therapeut Program, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2547
引用
收藏
页码：647A / 648A
页数：2
相关论文
共 23 条
  • [21] Prior therapy with rituximab (R) in patients (pts) with diffuse large B-Cell lymphoma (DLBCL) does not affect disease-free (DFS) or overall survival (OS) following high dose therapy (HDT) and autologous stem cell transplantation (ASCT).
    Thakkar, Snehal G.
    Sweetenham, John William
    Rybicki, Lisa
    Sobecks, Ronald
    Andresen, Steven
    Dean, Robert M.
    Pohlman, Brad
    Kang, Tyler Y.
    Kalaycio, Matt
    Brown, Stacey
    Bolwell, Brian J.
    BLOOD, 2006, 108 (11) : 869A - 870A
  • [22] Mature Results of BEAM/High-Dose Rituximab Vs BEAM/Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) and Autologous Stem Cell Transplantation (ASCT) for Relapsed CD20+ Follicular and Diffuse Large B-Cell Lymphoma: Survival Outcomes and Risk of Secondary Malignancies
    Zipp, Lisa
    Saliba, Rima M.
    Valverde, Rosamar
    Okoroji, Grace-Julia
    Korbling, Martin
    Samuels, Barry I.
    Abruzzo, Lynne V.
    Alousi, Amin M.
    Andersson, Borje S.
    Hosing, Chitra M.
    Erwin, Bill
    Anderlini, Paolo
    Popat, Uday R.
    Kebriaei, Partow
    Macapinlac, Homer A.
    Champlin, Richard
    Khouri, Issa F.
    BLOOD, 2011, 118 (21) : 875 - 876
  • [23] The Addition of Rituximab to CVP (Bagley) plus Interferon-α as Induction Regimen, Significantly Increases Complete Remission Rates and Progression Free Survival In Intermediate-High Risk Follicular Lymphoma Patients (LNH-pro vs. LNH-pro-05 trial)
    Cannata-Ortiz, Jimena
    Nicolas, Concepcion
    Garcia-Noblejas, Ana
    Lopez, Javier
    Jose Requena, Maria
    Alaez, Concepcion
    Alegre, Adrian
    Arranz, Reyes
    BLOOD, 2010, 116 (21) : 1180 - 1181
123